We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 3 of 4 for:    small cell lung cancer BMN 673

Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02537561
Recruitment Status : Withdrawn (The pharmaceutical company did not want to follow through with support for the study.)
First Posted : September 1, 2015
Last Update Posted : February 11, 2016
BioMarin Pharmaceutical
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2018
  Estimated Study Completion Date : December 2018